Related by context. Frequent words. (Click for all words.) 73 Patent License Agreement 65 Exclusive License 64 Patent Lawsuit 63 Files Patent Infringement 63 Patent Dispute 62 Patent Infringement Case 62 Licensing Deal 61 Licensing Agreements 61 Patent Portfolio 60 Commercialization Agreement 60 Achieves Milestone 60 Reseller Agreement 60 Distribution Agreements 59 Collaboration Agreement 59 Develop Next Generation 59 Acacia Subsidiary Enters 59 Licensing Agreement 59 Patent Litigation 58 Teaming Agreement 58 Signs Licensing Agreement 58 Patent Infringement 58 Exclusive Distribution 58 Receives Patent 58 Supply Agreements 58 Announces Definitive Agreement 58 Distributor Agreement 57 License Agreement 57 FDA Clears 57 Patent Suit 56 Completes Tender Offer 56 Distribution Agreement 56 Acquire Assets 56 Files Patent 55 Receives FDA Clearance 55 Complete Merger 55 License Agreements 55 Completes Enrollment 55 Signs Distribution 55 Expand Relationship 54 Introduces Enhanced 54 Option Grants 54 Alseres Pharmaceuticals Inc. 54 Secures Additional 54 Licence Agreement 54 Extends Tender Offer 54 Subsidiary Signs 54 Awarded Patent 53 Technol 53 Definitive Agreements 53 Patent Licensing 53 Subsidiary Receives 53 Introduces Next Generation 53 Closes Financing 53 Drug Candidate 53 Completes Merger 53 Stock Repurchase Plan 53 Stockholders Approve Merger 53 Announces Issuance 53 Q2 Loss Narrows 53 Enters Agreement 52 Announce Collaboration 52 Explore Strategic Alternatives 52 Strategic Relationship 52 Enters Strategic 52 Q3 Loss Widens 52 Shareholder Investigation 52 Ceragenix 52 Q2 Loss Widens 52 Files Annual Report 52 FDA Accepts 52 Share Repurchase Plan 52 Announces Initiation 52 Jointly Develop 52 Acquires Exclusive 52 Announces Intent 52 Supply Agreement 52 Privately Held 52 Permanent Injunction 52 Announces Termination 52 Regains Compliance 52 Provide Comprehensive 52 Small Molecule 52 Q1 Loss Widens 52 Secures Contract 52 Signs Agreements 52 Clinical Trial Results 52 Finalizes Acquisition 52 Announce Joint Venture 52 Q3 Loss Narrows 51 Begins Shipping 51 Confidentiality Agreement 51 Power3 Medical 51 Seeks Approval 51 Q1 Loss Narrows 51 Secures Funding 51 Generic Version 51 Spins Off 51 Shelf Registration Statement 51 Announces Organizational Changes 51 Commercialize 51 OPTi